Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists
- 5 July 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (13) , 3501-3505
- https://doi.org/10.1016/j.bmcl.2004.04.070
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonistsBioorganic & Medicinal Chemistry Letters, 2004
- Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1Nature, 2004
- Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseasesEmerging Drugs, 2003
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate ReceptorsJournal of Biological Chemistry, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002
- Lysophospholipid ReceptorsAnnual Review of Pharmacology and Toxicology, 2001
- Highly Active Palladium Catalysts for Suzuki Coupling ReactionsJournal of the American Chemical Society, 1999
- New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical DevelopmentJournal of Medicinal Chemistry, 1998
- An improved oxadiazole synthesis using peptide coupling reagentsTetrahedron Letters, 1996
- A useful 12-I-5 triacetoxyperiodinane (the Dess-Martin periodinane) for the selective oxidation of primary or secondary alcohols and a variety of related 12-I-5 speciesJournal of the American Chemical Society, 1991